Smith Jason Drew sold URGN
September 8, 2025 · Form 4 insider transaction
Smith Jason Drew sold 1,520 shares of UroGen Pharma Ltd. at $19.11 per share, a transaction worth $29.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,520
Price
$19.11
Total value
$29.0K
InsiderSmith Jason Drew
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateSeptember 8, 2025
Filing dateSeptember 9, 2025
Shares owned after43,305
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.